Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris
- PMID: 21354482
- PMCID: PMC3388602
- DOI: 10.1016/j.vaccine.2011.02.036
Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris
Abstract
Propionibacterium acnes (P. acnes) bacteria play a key role in the pathogenesis of acne vulgaris. Although our previous studies have demonstrated that vaccines targeting a surface sialidase or bacterial particles exhibit a preventive effect against P. acnes, the lack of therapeutic activities and incapability of neutralizing secretory virulence factors motivate us to generate novel immunotherapeutics. In this study, we develop an immunotherapeutic antibody to secretory Christie-Atkins-Munch-Peterson (CAMP) factor of P. acnes. Via agroinfiltration, P. acnes CAMP factor was encapsulated into the leaves of radishes. ICR mice intranasally immunized with whole leaves expressing CAMP factor successfully produced neutralizing antibodies that efficiently attenuated P. acnes-induced ear swelling and production of macrophage-inflammatory protein-2. Passive neutralization of CAMP factor enhanced immunity to eradicate P. acnes at the infection site without influencing bacterial growth elsewhere. We propose that CAMP factor is a novel therapeutic target for the treatment of various P. acnes-associated diseases and highlight the concept of neutralizing P. acnes virulence without disturbing the bacterial commensalism in human microbiome.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures





Similar articles
-
Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.Expert Rev Vaccines. 2019 May;18(5):433-437. doi: 10.1080/14760584.2019.1593830. Epub 2019 Mar 28. Expert Rev Vaccines. 2019. PMID: 30920859 Review.
-
The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.J Invest Dermatol. 2018 Nov;138(11):2355-2364. doi: 10.1016/j.jid.2018.05.032. Epub 2018 Jun 30. J Invest Dermatol. 2018. PMID: 29964032
-
Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment.PLoS One. 2011 Apr 12;6(4):e14797. doi: 10.1371/journal.pone.0014797. PLoS One. 2011. PMID: 21533261 Free PMC article.
-
Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting β-hemolysin and CAMP factor.J Invest Dermatol. 2011 Feb;131(2):401-9. doi: 10.1038/jid.2010.319. Epub 2010 Nov 18. J Invest Dermatol. 2011. PMID: 21085191 Free PMC article.
-
Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.Curr Drug Metab. 2015;16(4):245-54. doi: 10.2174/1389200216666150812124801. Curr Drug Metab. 2015. PMID: 26264195 Review.
Cited by
-
Vaccines in Dermatology-Present and Future: A Review.Vaccines (Basel). 2025 Jan 26;13(2):125. doi: 10.3390/vaccines13020125. Vaccines (Basel). 2025. PMID: 40006672 Free PMC article. Review.
-
Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.J Invest Dermatol. 2016 Nov;136(11):2221-2228. doi: 10.1016/j.jid.2016.06.615. Epub 2016 Jul 1. J Invest Dermatol. 2016. PMID: 27377696 Free PMC article.
-
A Microtube Array Membrane (MTAM) Encapsulated Live Fermenting Staphylococcus epidermidis as a Skin Probiotic Patch against Cutibacterium acnes.Int J Mol Sci. 2018 Dec 20;20(1):14. doi: 10.3390/ijms20010014. Int J Mol Sci. 2018. PMID: 30577530 Free PMC article.
-
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.Clin Microbiol Rev. 2014 Jul;27(3):419-40. doi: 10.1128/CMR.00092-13. Clin Microbiol Rev. 2014. PMID: 24982315 Free PMC article. Review.
-
Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.EuPA Open Proteom. 2015 Dec;9:1-7. doi: 10.1016/j.euprot.2015.06.003. Epub 2015 Jun 16. EuPA Open Proteom. 2015. PMID: 28083470 Free PMC article.
References
-
- Dekio I, Sakamoto M, Hayashi H, Amagai M, Suematsu M, Benno Y. Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J Med Microbiol. 2007;56(Pt 12):1675–1683. - PubMed
-
- Brook I, Frazier EH. Infections caused by Propionibacterium species. Rev Infect Dis. 1991;13(5):819–822. - PubMed
-
- Ahn CY, Ko CY, Wagar EA, Wong RS, Shaw WW. Microbial evaluation: 139 implants removed from symptomatic patients. Plast Reconstr Surg. 1996;98(7):1225–1229. - PubMed
-
- Tancrede C. Role of human microflora in health and disease. Eur J Clin Microbiol Infect Dis. 1992;11(11):1012–1015. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical